Profiling the intestinal microbiota, plasma bile acids and inflammation markers reveals novel associations in Crohn's disease and Ulcerative colitis.
Stefanie Prast‐NielseniD, Anna Löf GranströmiD, Ali KiasatiD, Gustav Ahlström, Gabriella EdfeldtiD, Susanne RautiaineniD, Fredrik BoulundiD, Fredrik O Andersson, Johan Lindberg, Ina Schuppe‐KoistineniD, Ulf O GustafssoniD, Lars G. EngstrandiD
Abstract
Background and aimsOur study explores signatures for Crohns disease (CD) and Ulcerative Colitis (UC) reflecting the interplay between the intestinal microbiota, systemic inflammation, and plasma bile acid homeostasis. Methods1,257 individuals scheduled for colonoscopy were included and completed a comprehensive questionnaire. Individuals with IBD ( CD n=64 and UC n= 55), were age- and gender-matched to controls without findings during colonoscopy. Taxonomic profiles of the fecal microbiota and plasma profiles of inflammatory proteins and bile acids were used to build disease classifiers. Omics integration identified associations across datasets. ResultsB. hydrogenotrophica was associated with CD and C. eutactus, C. sp. CAG 167, B. cellulosilyticus, C. mitsuokai with controls. Ten inflammation markers were increased in CD, and eleven bile acids and derivatives were decreased in CD, while 7a-Hydroxy-3-oxo-4-cholestenoate (7-HOCA) and chenodeoxycholic acid (CDCA) were increased compared to controls. In UC, commensals such as F. prausnitzii and A. muciniphila were depleted. CCL11, IL-17A, and TNF were increased in UC and associated to gut microbial changes. Correlations between taxa and bile acids were all positive. ConclusionsFor both CD and UC, taxonomic differences were primarily characterized by a reduction in commensal gut microbes which exhibited positive correlations with secondary bile acids and negative correlations with inflammation markers, potentially reflecting protective mechanisms of these commensal microbes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease
N. Chamorro, D. A. Montero, … R. M. Vidal·Microbial CellPeer-reviewed·Sep 6, 2021
- Inferring intestinal mucosal immune cell associated microbiome species and microbiota-derived metabolites in inflammatory bowel disease
Rajagopalan Lakshmi Narasimhan, Allison A. Throm, … Jiajian Liu·bioRxiv·Sep 18, 2020
- Systematic Mining of gut microbiota biomarkers for IBD
Yuchen Zhang, Wenkai Lai, … Fenglong Yang·bioRxiv·Oct 10, 2024
- Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives using fecal metagenomics and metabolomics
Wanning Chen, Yichen Li, … Ruixin Zhu·Cell Reports MedicinePeer-reviewed·Jun 27, 2024
- Dynamics and fermentation patterns of stool microbiota on simple carbon sources in in vitro batch cultures reveal dysbiosis in Crohn's disease.
Anna Detman, Gabriele Schiro, … Anna Sikora·Microbial Cell FactoriesPeer-reviewed·Aug 3, 2026
- Variability of core microbiota in newly diagnosed treatment-naïve paediatric Inflammatory Bowel Disease patients
T. G. J. de Meij, E. de Groot, … D. Budding·bioRxiv·May 8, 2018